Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice

Molecular Nutrition and Food Research

Volumn 60, Issue 3, 2016, Pages 609-620

  Lecomte, Manon ^a   Couëdelo, Leslie ^b   Meugnier, Emmanuelle ^c   Plaisancié, Pascale ^a   Létisse, Marion ^a   Benoit, Bérengère ^a   Gabert, Laure ^c,d   Penhoat, Armelle ^a   Durand, Annie ^a   Pineau, Gaëlle ^a   Joffre, Florent ^b   Géloën, Alain ^a   Vaysse, Carole ^b   Laugerette, Fabienne ^a   Michalski, Marie Caroline ^a,d  

^a Univ Lyon   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CarMeN   (France)

^d Univ Lyon   (France)

Author keywords

Caco 2; Feces; Gut barrier; Metabolic disease; Phospholipid

Indexed keywords

EMULSIFYING AGENT; LIPID; PHOSPHATIDYLCHOLINE;

ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CACO-2 CELL LINE; CHEMICALLY INDUCED; CHEMISTRY; COLON; CYTOLOGY; DRUG EFFECTS; GOBLET CELL; HUMAN; LIPID DIET; LIVER; LOW FAT DIET; MALE; METABOLISM; MILK; OBESITY; PANNICULITIS; SOYBEAN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; CACO-2 CELLS; COLON; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; EMULSIFYING AGENTS; GOBLET CELLS; HUMANS; LECITHINS; LIPIDS; LIVER; MALE; MICE, INBRED C57BL; MILK; PANNICULITIS; SOYBEANS;

EID: 84959525514     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500703     Document Type: Article

References (58)

1. Jo, J., Gavrilova, O., Pack, S., Jou, W. et al., Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput. Biol. 2009, 5, e1000324.
2. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
3. Maury, E., Brichard, S. M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 2010, 314, 1-16.
4. Moreno-Navarrete, J. M., Escote, X., Ortega, F., Serino, M. et al., A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 2013, 56, 2524-2537.
5. Ouchi, N., Parker, J. L., Lugus, J. J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97.
6. Petit, V., Arnould, L., Martin, P., Monnot, M. C. et al., Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J. Lipid Res. 2007, 48, 278-287.
7. Benoit, B., Plaisancie, P., Geloen, A., Estienne, M. et al., Pasture v. standard dairy cream in high-fat diet-fed mice: improved metabolic outcomes and stronger intestinal barrier. Br. J. Nutr. 2014, 112, 520-535.
8. Hamilton, M. K., Boudry, G., Lemay, D. G., Raybould, H. E., Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am. J. Physiol. 2015, 308, G840-G851.
9. de Wit, N. J., Bosch-Vermeulen, H., de Groot, P. J., Hooiveld, G. J. et al., The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med. Genomics 2008, 1, 1755-8794.
10. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
11. Benoit, B., Bruno, J., Kayal, F., Estienne, M. et al., Saturated and unsaturated fatty acids differently modulate colonic goblet cells in vitro and in rat pups. J. Nutr. 2015, 145, 1754-1762.
12. Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C. et al., Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015, 519, 92-96.
13. Burling, H., Nilsson, A., Ohlsson, L., Inform, AOCS Urbana, Illinois 2009, pp. 494-496.
14. Polichetti, E., Diaconescu, N., De La Porte, P. L., Malli, L. et al., Cholesterol-lowering effect of soyabean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br. J. Nutr. 1996, 75, 471-478.
15. Ide, T., Combined effect of sesamin and soybean phospholipid on hepatic fatty acid metabolism in rats. J. Clin. Biochem. Nutr. 2014, 54, 210-218.
16. Chang, J. H., Kim, M. S., Kim, T. W., Lee, S. S., Effects of soybean supplementation on blood glucose, plasma lipid levels, and erythrocyte antioxidant enzyme activity in type 2 diabetes mellitus patients. Nutr. Res. Pract. 2008, 2, 152-157.
17. LeBlanc, M. J., Brunet, S., Bouchard, G., Lamireau, T. et al., Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats. J. Nutr. Biochem. 2003, 14, 40-48.
18. Couedelo, L., Amara, S., Lecomte, M., Meugnier, E. et al., Impact of various emulsifiers on ALA bioavailability and chylomicron synthesis through changes in gastrointestinal lipolysis. Food Funct. 2015, 6, 1726-1735.
19. Castro-Gomez, P., Garcia-Serrano, A., Visioli, F., Fontecha, J., Relevance of dietary glycerophospholipids and sphingolipids to human health. Prostaglandins Leukot. Essent. Fatty Acids 2015, 101, 41-51.
20. Noh, S. K., Koo, S. I., Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. J. Nutr. 2004, 134, 2611-2616.
21. Ramprasath, V. R., Jones, P. J. H., Buckley, D. D., Woollett, L. A. et al., Effect of dietary sphingomyelin on absorption and fractional synthetic rate of cholesterol and serum lipid profile in humans. Lipids Health Dis. 2013, 12, 12-125.
22. Wat, E., Tandy, S., Kapera, E., Kamili, A. et al., Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 2009, 205, 144-150.
23. Zhou, A. L., Hintze, K. J., Jimenez-Flores, R., Ward, R. E., Dietary fat composition influences tissue lipid profile and gene expression in Fischer-344 rats. Lipids 2012, 47, 1119-1130.
24. Reis, M. G., Roy, N. C., Bermingham, E. N., Ryan, L. et al., Impact of dietary dairy polar lipids on lipid metabolism of mice fed a high-fat diet. J. Agric. Food Chem. 2013, 61, 2729-2738.
25. Snow, D. R., Ward, R. E., Olsen, A., Jimenez-Flores, R. et al., Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. J. Dairy Sci. 2011, 94, 2201-2212.
26. Plaisancie, P., Claustre, J., Estienne, M., Henry, G. et al., A novel bioactive peptide from yoghurts modulates expression of the gel-forming MUC2 mucin as well as population of goblet cells and Paneth cells along the small intestine. J. Nutr. Biochem. 2013, 24, 213-221.
27. Couedelo, L., Boue-Vaysse, C., Fonseca, L., Montesinos, E. et al., Lymphatic absorption of alpha-linolenic acid in rats fed flaxseed oil-based emulsion. Br. J. Nutr. 2011, 105, 1026-1035.
28. Leseigneur-Meynier, A., Gandemer, G., Marion, D., Congrès International Chevreul pour l'Etude des Corps Gras, ETIG, Paris 1989, pp. 311-318.
29. Vors, C., Capolino, P., Guerin, C., Meugnier, E. et al., Coupling in vitro gastrointestinal lipolysis and Caco-2 cell cultures for testing the absorption of different food emulsions. Food Funct. 2012, 3, 537-546.
30. Soula, H. A., Julienne, H., Soulage, C. O., Geloen, A., Modelling adipocytes size distribution. J. Theor. Biol. 2013, 332, 89-95.
31. Awada, M., Meynier, A., Soulage, C. O., Hadji, L. et al., n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice. Nutr. Metab. 2013, 10, 1-14.
32. Zoghbi, S., Trompette, A., Claustre, J., El Homsi, M. et al., beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway. Am. J. Physiol. 2006, 290, G1105-G1113.
33. Gabert, L., Vors, C., Louche-Pelissier, C., Sauvinet, V. et al., 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1, 1, 1-13C3]tripalmitin and [1, 1, 1-13C3]triolein. Rapid Commun. Mass Spectrom. 2011, 25, 2697-2703.
34. Kim, K. A., Gu, W., Lee, I. A., Joh, E. H. et al., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7, e47713.
35. Lam, Y. Y., Ha, C. W., Hoffmann, J. M., Oscarsson, J. et al., Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice. Obesity 2015, 23, 1429-1439.
36. Cohn, J. S., Kamili, A., Wat, E., Chung, R. W. S. et al., Dietary phospholipids and intestinal cholesterol absorption. Nutrients 2010, 2, 116-127.
37. Burgess, J. W., Boucher, J., Neville, T. A., Rouillard, P. et al., Phosphatidylinositol promotes cholesterol transport and excretion. J. Lipid Res. 2003, 44, 1355-1363.
38. Noh, S. K., Koo, S. I., Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. J. Nutr. 2004, 134, 2611-2616.
39. Eckhardt, E. R., Wang, D. Q., Donovan, J. M., Carey, M. C., Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002, 122, 948-956.
40. Herrmann, T., Buchkremer, F., Gosch, I., Hall, A. M. et al., Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene 2001, 270, 31-40.
41. Lecomte, M., Bourlieu, C., Meugnier, E., Penhoat, A. et al., Milk polar lipids affect in vitro digestive lipolysis and postprandial lipid metabolism in mice. J. Nutr. 2015, 145, 1770-1777.
42. Pelaseyed, T., Bergstrom, J. H., Gustafsson, J. K., Ermund, A. et al., The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol. Rev. 2014, 260, 8-20.
43. Poirier, H., Degrace, P., Niot, I., Bernard, A. et al., Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Eur. J. Biochem. 1996, 238, 368-373.
44. Vors, C., Pineau, G., Gabert, L., Drai, J. et al., Modulating absorption and postprandial handling of dietary fatty acids by structuring fat in the meal: a randomized crossover clinical trial. Am. J. Clin. Nutr. 2013, 97, 23-36.
45. Alligier, M., Gabert, L., Meugnier, E., Lambert-Porcheron, S. et al., Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J. Clin. Endocrinol. Metab. 2013, 98, 802-810.
46. Skurk, T., Alberti-Huber, C., Herder, C., Hauner, H., Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92, 1023-1033.
47. Ohashi, K., Ouchi, N., Matsuzawa, Y., Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 2012, 94, 2137-2142.
48. Otero, M., Lago, R., Gomez, R., Lago, F. et al., Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drug News Perspect. 2006, 19, 21-26.
49. Laugerette, F., Furet, J. P., Debard, C., Daira, P. et al., Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E374-E386.
50. Moreno-Navarrete, J. M., Escote, X., Ortega, F., Camps, M. et al., Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation. Diabetologia 2015, 58, 2424-2434.
51. Treede, I., Braun, A., Sparla, R., Kuhnel, M. et al., Anti-inflammatory effects of phosphatidylcholine. J. Biol. Chem. 2007, 282, 27155-27164.
52. Jung, Y. Y., Nam, Y., Park, Y. S., Lee, H. S. et al., Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury. Korean J. Physiol. Pharmacol. 2013, 17, 209-216.
53. Moreira, A. P., Texeira, T. F., Ferreira, A. B., Peluzio Mdo, C. et al., Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br. J. Nutr. 2012, 108, 801-809.
54. Hamilton, M. K., Boudry, G., Lemay, D. G., Raybould, H. E., Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am. J. Physiol. 2015, 308, G840-G851.
55. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A. et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470-1481.
56. Johansson, M. E., Mucus layers in inflammatory bowel disease. Inflamm. Bowel Dis. 2014, 20, 2124-2131.
57. Martinez, F. O., Sica, A., Mantovani, A., Locati, M., Macrophage activation and polarization. Front. Biosci. 2008, 13, 453-461.
58. Nilsson, A., Duan, R. D., Absorption and lipoprotein transport of sphingomyelin. J. Lipid Res. 2006, 47, 154-171.